tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2020 Jun 10;8(2):E293.
doi: 10.3390/vaccines8020293.
Prospects of Replication-Deficient Adenovirus Based Vaccine Development Against SARS-CoV-2
Mariangela Garofalo[SUP] 1 [/SUP], Monika Staniszewska[SUP] 2 [/SUP], Stefano Salmaso[SUP] 1 [/SUP], Paolo Caliceti[SUP] 1 [/SUP], Katarzyna Wanda Pancer[SUP] 3 [/SUP], Magdalena Wieczorek[SUP] 3 [/SUP], Lukasz Kuryk[SUP] 3 4 [/SUP]
Affiliations
Abstract
The current appearance of the new SARS coronavirus 2 (SARS-CoV-2) and it quickly spreading across the world poses a global health emergency. The serious outbreak position is affecting people worldwide and requires rapid measures to be taken by healthcare systems and governments. Vaccinations represent the most effective strategy to prevent the epidemic of the virus and to further reduce morbidity and mortality with long-lasting effects. Nevertheless, currently there are no licensed vaccines for the novel coronaviruses. Researchers and clinicians from all over the world are advancing the development of a vaccine against novel human SARS-CoV-2 using various approaches. Herein, we aim to present and discuss the progress and prospects in the field of vaccine research towards SARS-CoV-2 using adenovirus (AdV) replication deficient-based strategies, with a comprehension that may support research and combat this recent world health emergency.
Keywords: COVID-19; SARS-CoV-2; adenovirus; adjuvant; vaccine.
. 2020 Jun 10;8(2):E293.
doi: 10.3390/vaccines8020293.
Prospects of Replication-Deficient Adenovirus Based Vaccine Development Against SARS-CoV-2
Mariangela Garofalo[SUP] 1 [/SUP], Monika Staniszewska[SUP] 2 [/SUP], Stefano Salmaso[SUP] 1 [/SUP], Paolo Caliceti[SUP] 1 [/SUP], Katarzyna Wanda Pancer[SUP] 3 [/SUP], Magdalena Wieczorek[SUP] 3 [/SUP], Lukasz Kuryk[SUP] 3 4 [/SUP]
Affiliations
- PMID: 32531955
- DOI: 10.3390/vaccines8020293
Abstract
The current appearance of the new SARS coronavirus 2 (SARS-CoV-2) and it quickly spreading across the world poses a global health emergency. The serious outbreak position is affecting people worldwide and requires rapid measures to be taken by healthcare systems and governments. Vaccinations represent the most effective strategy to prevent the epidemic of the virus and to further reduce morbidity and mortality with long-lasting effects. Nevertheless, currently there are no licensed vaccines for the novel coronaviruses. Researchers and clinicians from all over the world are advancing the development of a vaccine against novel human SARS-CoV-2 using various approaches. Herein, we aim to present and discuss the progress and prospects in the field of vaccine research towards SARS-CoV-2 using adenovirus (AdV) replication deficient-based strategies, with a comprehension that may support research and combat this recent world health emergency.
Keywords: COVID-19; SARS-CoV-2; adenovirus; adjuvant; vaccine.